Published ahead of print on July 27, 2006, doi:10.1165/rcmb.2006-0018OC
Am. J. Respir. Cell Mol. Biol., Volume 36, Number 1, January 2007, 20-31
A more recent version of this article appeared on January 1, 2007
Submitted on January 17, 2006
Revised on July 25, 2006
TSG-6 Potentiates the Anti Tissue Kallikrein Activity of Inter- -inhibitor through Bikunin Release
Rosanna Forteza1*, Susana M Casalino-Matsuda1, Maria Elena Monzon1, Erik Fries2, Marilyn S Rugg3, Caroline M Milner3, and Anthony J Day4
1 Division of Pulmonary and Critical Care Medicine, University of Miami, Miller School of Medicine, Miami, FL, USA,
2 Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Center, Uppsala, Sweden,
3 Department of Biochemistry, MRC Immunochemistry Unit, University of Oxford, Oxford, United Kingdom,
4 Department of Biochemistry, MRC Immunochemistry Unit, University of Oxford, Oxford, United Kingdom; Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom
* To whom correspondence should be addressed. E-mail: rforteza{at}miami.edu.
TSG-6 (the protein product of TNF-stimulated gene-6), an inflammation-associated protein, forms covalent complexes with heavy chains (HC) from inter- -inhibitor (I I) and pre- -inhibitor (P I), and associates non-covalently with their common bikunin chain, potentiating the anti-plasmin activity of this serine protease inhibitor. Here we show that TSG-6 and TSG-6[[rad]]HC complexes are present in bronchoalveolar lavage from asthmatics and increase following allergen challenge. Immunodetection demonstrated elevated TSG-6 in airway tissue and secretions of smokers. Experiments conducted in vitro with purified components revealed that bikunin[[rad]]HC complexes (byproducts of TSG-6[[rad]]HC formation) release bikunin. Immunoprecipitation revealed that bikunin accounts for a significant proportion of tissue kallikrein inhibition in BAL after allergen challenge but not in baseline conditions, confirming that bikunin in its free state, but not when associated with HCs, is a relevant protease inhibitor in airway secretions. In primary cultures of differentiated human airway epithelial and submucosal gland cells TSG-6 is induced by TNF- and IL-1 pointing towards those cells as responsible for TSG-6 release in vivo. Bikunin and HC3 (i.e., P I) were also induced by TNF- in primary cultures. Our results suggest that TSG-6 may play an important protective role in bronchial epithelium by increasing the antiprotease screen on the airway lumen.
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Mahoney, K. Mikecz, T. Ali, G. Mabilleau, D. Benayahu, A. Plaas, C. M. Milner, A. J. Day, and A. Sabokbar
TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
J. Biol. Chem.,
September 19, 2008;
283(38):
25952 - 25962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Sanggaard, C. S. Sonne-Schmidt, T. P. Krogager, K. A. Lorentzen, H.-G. Wisniewski, I. B. Thogersen, and J. J. Enghild
The Transfer of Heavy Chains from Bikunin Proteins to Hyaluronan Requires Both TSG-6 and HC2
J. Biol. Chem.,
July 4, 2008;
283(27):
18530 - 18537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Blundell, D. J. Mahoney, M. R. Cordell, A. Almond, J. D. Kahmann, A. Perczel, J. D. Taylor, I. D. Campbell, and A. J. Day
Determining the Molecular Basis for the pH-dependent Interaction between the Link Module of Human TSG-6 and Hyaluronan
J. Biol. Chem.,
April 27, 2007;
282(17):
12976 - 12988.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society.
|
|
|